← Eichor
Condition: Brain And Central Nervous System Tumors Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Brain And Central Nervous System Tumors

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac
Phase 3 · 590 location(s) · SWOG Cancer Research Network · NCT03418961Clinical Trial of an Anti-Fog Drainage Device for Endoscopic Endonasal Sellar Region Tumor Surgery
NA · 1 location(s) · West China Hospital · NCT07316101rTMS for Postoperative Brain Tumor Patients
NA · 1 location(s) · Brian J.Gill · NCT07530536Superiority Trial Evaluating Digitalized Information Media for Patients With Advanced Sarcomas Receiving Systemic Treatm
NA · 11 location(s) · Centre Oscar Lambret · NCT06211257Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Phase 1/Phase 2 · 27 location(s) · Institut de Recherches Internationales Servier · NCT05786924Postop Pain Management in Pituitary Tumour Patients
Phase 4 · 1 location(s) · Hamilton Health Sciences Corporation · NCT06353529The "Let's Talk Tech" Tool to Support Decision Making About Technology Use
NA · 1 location(s) · University of Washington · NCT06817122Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation
EARLY_Phase 1 · 12 location(s) · C17 Council · NCT06942039Immune Checkpoint Inhibitor Associated Cardiovascular Adverse Events in Patients With Cancer
Phase N/A · 1 location(s) · Hanneke W. M. van Laarhoven · NCT06519292Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc
Phase 1 · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT05366179Prognostic Value of Neurometabolic Networks in CRC (PVNM-CRC)
Phase N/A · 1 location(s) · The First Affiliated Hospital of Zhengzhou University · NCT06930586A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease P
Phase 2 · 2 location(s) · Elixiron Immunotherapeutics Inc. · NCT06745583Neurocognition After Radiotherapy in CNS- and Skull-base Tumors
NA · 3 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT05727605Stupp Treatment With Intrathecal Injection of Thiotepa for Glioblastoma With Advanced Spread
Phase 2 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07193654Ovarian Tissue Cryopreservation in Pre-Pubertal (OTC-Pre Pubertal)
Phase N/A · 1 location(s) · Erin Rowell · NCT05299710KETOgenic Diet Therapy in Patients With ACROmegaly
NA · 1 location(s) · Erasmus Medical Center · NCT06949891Motor Eloquent Navigated Transcranial Magnetic Stimulation for Radiosurgery Planning
NA · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT07415668Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared
Phase 3 · 1 location(s) · Northwell Health · NCT05271240Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Phase N/A · 1 location(s) · Institut Pasteur du Cambodge · NCT07358910WBRT With Hippocampal-avoidance Technique Followed by SRT for Extensive-stage SCLC With Baseline Brain Metastases
Phase 1/Phase 2 · 1 location(s) · Fudan University · NCT0624300368Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor Patients
EARLY_Phase 1 · 1 location(s) · Peking Union Medical College Hospital · NCT05549024Robot-Assisted Neurovascular Intervention
NA · 1 location(s) · Navigantis Inc. · NCT06752096Individualized Neuro-Modulation Paired With Cerebellar Therapy
NA · 1 location(s) · Hugo W. Moser Research Institute at Kennedy Krieger, Inc. · NCT07642856WBSI Guided Personalized Delivery of TTFields
NA · 2 location(s) · Abramson Cancer Center at Penn Medicine · NCT05086497Metabolic Characterization of Space Occupying Lesions of the Brain
Phase N/A · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT04233788Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Ref
Phase 2 · 1 location(s) · Northwell Health · NCT02800486C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)
Phase 1 · 1 location(s) · Baylor College of Medicine · NCT04099797SeOuL cOhort of Brain Tumor MONitoring Study (SOLOMON)
Phase N/A · 1 location(s) · Seoul National University Hospital · NCT05254197Cognitive Screening Made Easy for PCPs - Administrative Supplement
NA · 3 location(s) · University of Texas at Austin · NCT06928298Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory
Phase 1 · 2 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT03721068
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.